Information technologies have significantly contributed to the evolution of work over the last fifty years. At first, IT was primarily applied to automate back office, highly repetitive and fairly standardized tasks, such as financial transactions, payroll, and inventory management.
Customer self-service was arguably the commercial killer-app of the Web in the ’90s. Now giving way to SOA and web collaboration technology, and the SaaS
So where does that put the pharma and biotech industry, we are not so famous for collaboration within the industry. The blatant patent wars and the triumphs to outdo the competitor by developing better and blockbuster drugs have certainly not contributed much to the developemnt of Drug industry in ways that supported the end users/customers. Infact the majority of the big inventions in the last 25 years were borne out of intelligent observations rather than from technological marvels, most of them were the bi product or came across as a lightning discovery during some other research projects.
That role is changing atleast now IT is looked upon and using it to drive business innovation. The involvement is present at every department, from Collaborative drug designing, Online Data sharing, ERP, CRM, use of enterprise systems in clinical research and post launch studies and Business intelligence
Better adoption of IT can dramatically improve the efficiency of and drive business innovation even using internet to speedup clinical research
Its interesting to learn about Conformia a company that claims to do so by Product performance and life cycle managemnet software for pharmaceutical product development industry and people seem to take attention -SAP an Enterprise application provider has mae investment in joint collaboration with conformia
Perhaps it time we see some major investment and IT helping Pharma companies in post product launch studies, to this date pharma companies do not have enough access to pefroamce data of the drugs present in the market , since hopsitlas and GPs will not like to part with data. Perhaps cost effective IT services might help in avoiding vioxx like incidents by giving pharma companies access to patient data,
Such improvements can only cement the future of genomics /personnal medicine such as samller steps are taken in this direction such as the Large-Scale Medical Sequencing Clinical Research